Trends in management and outcome of hospitalized patients with acute stroke and transient ischemic attack: The national acute stroke israeli (nasis) registry

Stroke

Volumn 43, Issue 8, 2012, Pages 2136-2141

  Tanne, David ^a,b   Koton, Silvia ^a   Molshazki, Noa ^b   Goldbourt, Uri ^a   Shohat, Tamar ^a,c   Tsabari, Rakefet ^b   Grossman, Ehud ^a   Bornstein, Natan M ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

outcomes; registry; stroke management

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN SIZE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DISEASE REGISTRY; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL MANAGEMENT; HOSPITAL PATIENT; HUMAN; HYPERTENSION; ISRAEL; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SELECTION; PERCUTANEOUS THROMBECTOMY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REPERFUSION; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREND STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DATA INTERPRETATION, STATISTICAL; DRUG UTILIZATION; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; HYPOLIPIDEMIC AGENTS; ISCHEMIC ATTACK, TRANSIENT; ISRAEL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PATIENT CARE MANAGEMENT; REGISTRIES; RISK FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84864289874     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.647610     Document Type: Article

References (17)

1. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42:227-276.
2. European Stroke Organisation Executive Committee and Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
3. Tanne D, Streifler JY, Gross B, Lampl Y, Bornstein NM. Guidelines for the management of acute stroke-2005 [in Hebrew]. Harefuah. 2006; 145:82-89, 168.
4. Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, et al. The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation. 2011;123: 2167-2179.
5. Tanne D, Koton S, Goldbourt U, Grossman E, Koren-Morag N, Grin MS, et al. A national survey of acute cerebrovascular disease in Israel: burden, management, outcome and adherence to guidelines. Isr Med Assoc J. 2006;8:3-7.
6. Herndon R. Handbook of Neurologic Rating Scales. New York, NY: Demos Vermande; 1997.
7. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
8. Eriksson M, Jonsson F, Appelros P, Asberg KH, Norrving B, Stegmayr B, et al. Dissemination of thrombolysis for acute ischemic stroke across a nation: experiences from the Swedish stroke register, 2003 to 2008. Stroke. 2010;41:1115-1122.
9. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42: 1952-1955.
10. Fonarow GC, Reeves MJ, Smith EE, Saver JL, Zhao X, Olson DW, et al. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in Get With The Guidelines-Stroke. Circulation. 2010;3:291-302.
11. Hsieh FI, Lien LM, Chen ST, Bai CH, Sun MC, Tseng HP, et al. Get With the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get With the Guidelines-Stroke in Taiwan. Circulation. 2010;122:1116-1123.
12. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003;34:1106-1112.
13. Rudd AG, Hoffman A, Grant R, Campbell JT, Lowe D. Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry. 2011; 82:14-19.
14. Asberg S, Henriksson KM, Farahmand B, Asplund K, Norrving B, Appelros P, et al. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14 529 patients in the Swedish Stroke Register. Stroke. 2010;41:1338-1342.
15. Ovbiagele B. Nationwide trends in in-hospital mortality among patients with stroke. Stroke. 2010;41:1748-1754.
16. Biffi A, Devan WJ, Anderson CD, Cortellini L, Furie KL, Rosand J, et al. Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke. 2011;42:1314-1319.
17. Schwammenthal Y, Bornstein N, Schwammenthal E, Schwartz R, Goldbourt U, Tsabari R, Koton S, Grossman E, Tanne D. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Am J Cardiol. 2010;105:411-416.